Compendium of Cancer Genome Aberrations

Changes

MALE5:Volunteer Assignments and Opportunities (view source)

Revision as of 14:06, 25 February 2024

15,636 bytes added ,  14:06, 25 February 2024
no edit summary
Line 17: Line 17:  
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|[[MALE5:Clear_cell_renal_cell_carcinoma|Clear cell renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Multilocular_cystic_renal_neoplasm_of_low_malignant_potential|Multilocular cystic renal neoplasm of low malignant potential]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_papillary_adenoma|Renal papillary adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Papillary_renal_cell_carcinoma|Papillary renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Oncocytoma_of_the_kidney|Oncocytoma of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Chromophobe_renal_cell_carcinoma|Chromophobe renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Other_oncocytic_tumours_of_the_kidney|Other oncocytic tumours of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Collecting_duct_carcinoma|Collecting duct carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Clear_cell_papillary_renal_cell_tumour|Clear cell papillary renal cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mucinous_tubular_and_spindle_cell_carcinoma|Mucinous tubular and spindle cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Tubulocystic_renal_cell_carcinoma|Tubulocystic renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Acquired_cystic_disease-associated_renal_cell_carcinoma|Acquired cystic disease-associated renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Eosinophilic_solid_and_cystic_renal_cell_carcinoma|Eosinophilic solid and cystic renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_cell_carcinoma_NOS|Renal cell carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:TFE3-rearranged_renal_cell_carcinomas|TFE3-rearranged renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:TFEB-altered_renal_cell_carcinomas|TFEB-altered renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:ELOC_(formerly_TCEB1)-mutated_renal_cell_carcinoma|ELOC (formerly TCEB1)-mutated renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Fumarate_hydratase-deficient_renal_cell_carcinoma|Fumarate hydratase-deficient renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Succinate_dehydrogenase-deficient_renal_cell_carcinoma|Succinate dehydrogenase-deficient renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:ALK-rearranged_renal_cell_carcinomas|ALK-rearranged renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:SMARCB1-deficient_renal_medullary_carcinoma|SMARCB1-deficient renal medullary carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_adenoma|Metanephric adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_adenofibroma|Metanephric adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_stromal_tumour|Metanephric stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_kidney|Mixed epithelial and stromal tumour of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Classic_angiomyolipoma_/_PEComa_of_the_kidney|Classic angiomyolipoma / PEComa of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Epithelioid_angiomyolipoma_/_epithelioid_PEComa_of_the_kidney|Epithelioid angiomyolipoma / epithelioid PEComa of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_haemangioblastoma|Renal haemangioblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Juxtaglomerular_cell_tumour|Juxtaglomerular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renomedullary_interstitial_cell_tumour|Renomedullary interstitial cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Ossifying_renal_tumour_of_infancy|Ossifying renal tumour of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Congenital_mesoblastic_nephroma|Congenital mesoblastic nephroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Rhabdoid_tumour_of_the_kidney|Rhabdoid tumour of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Clear_cell_sarcoma_of_the_kidney|Clear cell sarcoma of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Nephrogenic_rests_|Nephrogenic rests]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Cystic_partially_differentiated_nephroblastoma|Cystic partially differentiated nephroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Nephroblastoma|Nephroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 435:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Germ_cell_tumours_of_the_kidney|Germ cell tumours of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 446:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urothelial_papilloma|Urothelial papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 457:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Inverted_urothelial_papilloma|Inverted urothelial papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 468:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Papillary_urothelial_neoplasm_of_low_malignant_potential|Papillary urothelial neoplasm of low malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 479:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_low-grade|Non-invasive papillary urothelial carcinoma, low-grade]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 490:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_high-grade|Non-invasive papillary urothelial carcinoma, high-grade]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 501:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urothelial_carcinoma_in_situ|Urothelial carcinoma in situ]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 512:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Invasive_urothelial_carcinoma|Invasive urothelial carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 523:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_papilloma_of_the_urothelial_tract|Squamous papilloma of the urothelial tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 534:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Verrucous_carcinoma_of_the_bladder|Verrucous carcinoma of the bladder]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 545:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Pure_squamous_carcinoma_of_the_urothelial_tract|Pure squamous carcinoma of the urothelial tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 556:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Villous_adenoma|Villous adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 567:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_NOS|Adenocarcinoma NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 578:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urachal_carcinoma|Urachal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 589:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Diverticular_carcinoma|Diverticular carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 600:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Littre_gland_adenocarcinoma_of_the_urethra|Littre gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 611:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Skene_gland_adenocarcinoma_of_the_urethra|Skene gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 622:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cowper_gland_adenocarcinoma_of_the_urethra|Cowper gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 633:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Clear_cell_adenocarcinoma_of_the_urinary_tract|Clear cell adenocarcinoma of the urinary tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 644:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Endometrioid_carcinoma_of_the_urinary_tract|Endometrioid carcinoma of the urinary tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 655:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_cystadenoma|Prostatic cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 666:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:High-grade_prostatic_intraepithelial_neoplasia|High-grade prostatic intraepithelial neoplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 677:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Intraductal_carcinoma_of_the_prostate|Intraductal carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 688:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_acinar_adenocarcinoma|Prostatic acinar adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 699:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_ductal_adenocarcinoma|Prostatic ductal adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Treatment-related_neuroendocrine_prostatic_carcinoma|Treatment-related neuroendocrine prostatic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Adenosquamous_carcinoma_of_the_prostate| Adenosquamous carcinoma of the prostate]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Squamous_cell_carcinoma_of_the_prostate| Squamous cell carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 743:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenoid_cystic_(basal_cell)_carcinoma_of_the_prostate| Adenoid cystic (basal cell) carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 754:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_stromal_tumour_of_uncertain_malignant_potential|Prostatic stromal tumour of uncertain malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 765:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_stromal_sarcoma|Prostatic stromal sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 776:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cystadenoma_of_the_seminal_vesicle|Cystadenoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 787:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_of_the_seminal_vesicle|Adenocarcinoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 798:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_cell_carcinoma_of_the_seminal_vesicle|Squamous cell carcinoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 809:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_seminal_vesicle|Mixed epithelial and stromal tumour of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 820:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Germ_cell_neoplasia_in_situ| Germ cell neoplasia in situ]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 831:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Specific_forms_of_intratubular_germ_cell_neoplasia| Specific forms of intratubular germ cell neoplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 842:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Gonadoblastoma| Gonadoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 853:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Seminoma| Seminoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 864:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Embryonal_carcinoma| Embryonal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 875:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Yolk_sac_tumour,_postpubertal-type| Yolk sac tumour, postpubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 886:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Choriocarcinoma| Choriocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 897:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Placental_site_trophoblastic_tumour| Placental site trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 908:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Epithelioid_trophoblastic_tumour| Epithelioid trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 919:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Cystic_trophoblastic_tumour| Cystic trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 930:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Teratoma,_postpubertal-type|Teratoma, postpubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 941:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Teratoma_with_somatic-type_malignancy|Teratoma with somatic-type malignancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 952:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mixed_germ_cell_tumours| Mixed germ cell tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 963:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Regressed_germ_cell_tumours| Regressed germ cell tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 974:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Spermatocytic_tumour|Spermatocytic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 985:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Teratoma,_prepubertal-type| Teratoma, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 996:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Yolk_sac_tumour,_prepubertal-type|Yolk sac tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 1,007:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Testicular_neuroendocrine_tumour,_prepubertal-type|Testicular neuroendocrine tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 1,018:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_teratoma_and_yolk_sac_tumour,_prepubertal-type|Mixed teratoma and yolk sac tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 1,029:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Leydig_cell_tumour| Leydig cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 1,040:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Sertoli_cell_tumour| Sertoli cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 1,051:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Large_cell_calcifying_Sertoli_cell_tumour|Large cell calcifying Sertoli cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 1,062:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adult_granulosa_cell_tumour| Adult granulosa cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 1,073:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Juvenile_granulosa_cell_tumour| Juvenile granulosa cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 1,084:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Tumours_in_the_fibroma_thecoma_group| Tumours in the fibroma thecoma group]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 1,095:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_sex_cord_stromal_tumour|Mixed sex cord stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 1,106:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Signet_ring_stromal_tumour|Signet ring stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 1,117:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Myoid_gonadal_stromal_tumour|Myoid gonadal stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 1,128:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Sex_cord_stromal_tumour_NOS|Sex cord stromal tumour NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 1,139:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_cystadenoma| Serous cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 1,150:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_tumour_of_borderline_malignancy| Serous tumour of borderline malignancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 1,161:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_cystadenocarcinoma| Serous cystadenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 1,172:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_cystadenoma| Mucinous cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 1,183:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_borderline_tumour| Mucinous borderline tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 1,194:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_cystadenocarcinoma| Mucinous cystadenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 1,205:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Endometrioid_tumours| Endometrioid tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 1,216:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Clear_cell_adenocarcinoma| Clear cell adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 1,227:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Brenner_tumour| Brenner tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 1,238:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenoma_of_the_collecting_ducts_and_rete_testis|Adenoma of the collecting ducts and rete testis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 1,249:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_of_the_collecting_ducts_and_rete_testis|Adenocarcinoma of the collecting ducts and rete testis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 1,260:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenomatoid_tumour| Adenomatoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 1,271:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Well-differentiated_papillary_mesothelial_tumour| Well-differentiated papillary mesothelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 1,282:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mesothelioma| Mesothelioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 1,293:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Cystadenoma_of_the_epididymis| Cystadenoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 1,304:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Papillary_cystadenoma_of_the_epididymis| Papillary cystadenoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,315:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenocarcinoma_of_the_epididymis| Adenocarcinoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,326:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_cell_carcinoma_of_the_epididymis|Squamous cell carcinoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,337:  
|
 
|
 
|-
 
|-
 +
|[[MALE5:_Melanotic_neuroectodermal_tumour_of_the_epididymis| Melanotic neuroectodermal tumour of the epididymis]]
 +
|Disease
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Condyloma_acuminatum|Condyloma acuminatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Penile_intraepithelial_neoplasia,_HPV-associated|Penile intraepithelial neoplasia, HPV-associated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Differentiated_penile_intraepithelial_neoplasia,_HPV-independent|Differentiated penile intraepithelial neoplasia, HPV-independent]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:HPV-associated_squamous_cell_carcinoma|HPV-associated squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:HPV-independent_squamous_cell_carcinoma|HPV-independent squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Squamous_cell_carcinoma_NOS| Squamous cell carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Penile_adenosquamous_and_mucoepidermoid_carcinomas| Penile adenosquamous and mucoepidermoid carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extramammary_Paget_disease|Extramammary Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Basal_cell_carcinoma_of_the_scrotum|Basal cell carcinoma of the scrotum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Well-differentiated_neuroendocrine_tumour|Well-differentiated neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mixed_neuroendocrine_neoplasms|Mixed neuroendocrine neoplasms]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Paraganglioma|Paraganglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:The_angiofibroma_family_of_tumours|The angiofibroma family of tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Haemangioma|Haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Myointimoma|Myointimoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Myopericytoma|Myopericytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extrarenal_PEComa|Extrarenal PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extranodal_marginal_zone_lymphoma_of_MALT|Extranodal marginal zone lymphoma of MALT]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Plasmacytoma|Plasmacytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Juvenile_xanthogranuloma| Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mucosal_melanoma|Mucosal melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_urinary_tract|Metastasis to the urinary tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_kidney|Metastasis to the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_testis_and_paratestis|Metastasis to the testis and paratestis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_papillary_renal_carcinoma|Hereditary papillary renal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome|Hereditary leiomyomatosis and renal cell carcinoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Succinate_dehydrogenase-deficient_tumour_syndromes|Succinate dehydrogenase-deficient tumour syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/14254"